GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Biopharmaceutical Corp (ROCO:6932) » Definitions » Cash Flow for Lease Financing

Mercury Biopharmaceutical (ROCO:6932) Cash Flow for Lease Financing : NT$-1.11 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Mercury Biopharmaceutical Cash Flow for Lease Financing?

Mercury Biopharmaceutical's Cash Flow for Lease Financing for the six months ended in Jun. 2024 was NT$-0.57 Mil. Mercury Biopharmaceutical's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 was NT$-1.11 Mil.

Compared with last quarter (NT$-0.54 Mil in Dec. 2023 ), Mercury Biopharmaceutical's Cash Flow for Lease Financing remained the same in Jun. 2024 (NT$-0.57 Mil).

Mercury Biopharmaceutical Cash Flow for Lease Financing Historical Data

The historical data trend for Mercury Biopharmaceutical's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mercury Biopharmaceutical Cash Flow for Lease Financing Chart

Mercury Biopharmaceutical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
- - -0.39 -0.99 -1.07

Mercury Biopharmaceutical Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only -0.46 -0.53 -0.53 -0.54 -0.57

Mercury Biopharmaceutical Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-1.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercury Biopharmaceutical Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Mercury Biopharmaceutical's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Mercury Biopharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mercury Biopharmaceutical Corp (ROCO:6932) » Definitions » Cash Flow for Lease Financing
Comparable Companies
TPE:4119 TPE:4746 TPE:1701 TPE:1720 ROCO:6785 ROCO:6576 TPE:3705 ROCO:4132 TPE:4108 ROCO:4166 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 653-1, Bannan Road, 15th Floor, Zhonghe District, New Taipei City, TWN
Website
https://www.merdury.com.tw
Mercury Biopharmaceutical Corp focuses on the development of drugs for unmet medical needs. It offers a development platform focusing on rapid release and free adjustable doses. Its 3D powder bonding method (binder jetting) combines powder and special molding adhesive and stacks them in layers.

Mercury Biopharmaceutical Headlines

No Headlines